Purported Mcl-1 inhibitor marinopyrrole A fails to show selective cytotoxicity for Mcl-1-dependent cell lines

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Eichhorn, J M ^a   Alford, S E ^a   Hughes, C C ^b   Fenical, W ^b   Chambers, T C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; MARINOPYRROLE A; NATURAL PRODUCT; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN MCL 1; UNCLASSIFIED DRUG;

CANCER CELL; COLON CARCINOMA; CYTOTOXICITY; DRUG HALF LIFE; GENE SILENCING; HELA CELL; LETTER; LEUKEMIA CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MURINE LEUKEMIA; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BIPHENYL COMPOUNDS; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA; NITROPHENOLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SULFONAMIDES;

EID: 84887498222     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.411     Document Type: Letter

References (56)

1. Wen PY. New developments in targeted molecular therapies for glioblastoma. Expert Rev Anticancer Ther 2009; 9: 7-10
2. Houillier C, Lejeune J, Benouaich-Amiel A, Laigle-Donadey F, Criniere E, Mokhtari K et al. Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer 2006; 106: 2218-2223
3. Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996
4. Taghian A, Suit H, Pardo F, Gioioso D, Tomkinson K, DuBois W et al. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int J of Radiat Oncol Biol Phys 1992; 23: 55-62
5. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760
6. Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature 2012; 481: 287-294
7. Russo AL, Kwon HC, Burgan WE, Carter D, Beam K, Weizheng X et al. In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016. Clin Cancer Res 2009; 15: 607-612
8. Wang Y, Li J, Booher RN, Kraker A, Lawrence T, Leopold WR et al. Radiosensitization of p53 mutant cells by PD0166285, a novel G2 checkpoint abrogator. Cancer Res 2001; 61: 8211-8217
9. Jin P, Gu Y, Morgan DO. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J Cell Biol 1996; 134: 963-970
10. Afshar G, Jelluma N, Yang X, Basila D, Arvold ND, Karlsson A et al. Radiation-induced caspase-8 mediates p53-independent apoptosis in glioma cells. Cancer Res 2006; 66: 4223-4232
11. Hara S, Nakashima S, Kiyono T, Sawada M, Yoshimura S, Iwama T et al. p53-independent ceramide formation in human glioma cells during g-radiation-induced apoptosis. Cell Death Differ 2004; 11: 853-861
12. Li F, Sethi G. Targeting transcription factor NF-kB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta 2010; 1805: 167-180
13. Vellanki SHK, Grabrucker A, Liebau S, Proepper C, Eramo A, Braun V et al. Small-molecule XIAP inhibitors enhance g-irradiation-induced apoptosis in glioblastoma. Neoplasia 2009; 11: 743-752
14. Kraus A, Gross MW, Knuechel R, Mü nkel K, Neff F, Schlegel J. Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53. J Neurosurg 2000; 93: 863-872
15. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR et al. Notch promotes radioresistance of glioma stem cells. Stem Cells 2009; 28: 17-28
16. Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ et al. Wnt activation is implicated in glioblastoma radioresistance. Lab Invest 2011; 92: 466-473
17. Li HF, Kim JS, Waldman T. Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells. Radiat Oncol 2009; 4: 43
18. Yount GL, Haas-Kogan DA, Vidair CA, Haas M, Dewey WC, Israel MA. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res 1996; 56: 500-506
19. Gartner A, Milstein S, Ahmed S, Hodgkin J, Hengartner MOA. Conserved checkpoint pathway mediates dna damage-induced apoptosis and cell cycle arrest in C. elegans. Mol Cell 2000; 5: 435-443
20. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C et al. Involvement of the MKK6-p38g cascade in g-radiation-induced cell cycle arrest. Mol Cell Biol 2000; 20: 4543-4552
21. Aziz K, Nowsheen S, Pantelias G, Iliakis G, Gorgoulis VG, Georgakilas AG. Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy. Pharmacol Ther 2012; 3: 334-350
22. Jin S, Antinore MJ, Lung FDT, Dong X, Zhao H, Fan F et al. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem 2000; 275: 16602-16608
23. Yang Q, Manicone A, Coursen JD, Linke SP, Nagashima M, Forgues M et al. Identification of a functional domain in a GADD45-mediated G2/M checkpoint. J Biol Chem 2000; 275: 36892-36898
24. Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA, OConnor PM. UCN-01: A potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J Natl Cancer Inst 1996; 88: 956-965
25. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432: 316-323
26. Lu X, Yang C, Hill R, Yin C, Hollander MC, Fornace AJ et al. Inactivation of gadd45a sensitizes epithelial cancer cells to ionizing radiation in vivo resulting in prolonged survival. Cancer Res 2008; 68: 3579-3583
27. Wouters BG, Giaccia AJ, Denko NC, Brown JM. Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res 1997; 57: 4703-4706
28. Giagkousiklidis S, Vogler M, Westhoff MA, Kasperczyk H, Debatin KM, Fulda S. Sensitization for g-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. Cancer Res 2005; 65: 10502-10513
29. Zhou L, Yuan R, Lanata S. Molecular mechanisms of irradiation-induced apoptosis. Front Biosci 2003; 8: D9-19
30. Karim A, Mccarthy K, Jawahar A, Smith D, Willis B, Nanda A. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines. Anticancer Res 2005; 25: 675-679
31. Chang HW, Roh JL, Jeong EJ, Lee S, Kim SW, Choi SH et al. Wnt signaling controls radiosensitivity via cyclooxygenase-2-mediated Ku expression in head and neck cancer. Int J Cancer 2007; 122: 100-107
32. Fassl A, Tagscherer K, Richter J, Diaz MB, Llaguno SRA, Campos B et al. Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1. Oncogene 2012; 31: 4698-4708
33. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 2005; 65: 2353-2363
34. Burton TR, Henson ES, Baijal P, Eisenstat DD, Gibson SB. The pro-cell death Bcl-2 family member, BNIP3, is localized to the nucleus of human glial cells: Implications for glioblastoma multiforme tumor cell survival under hypoxia. Int J Cancer 2005; 118: 1660-1669
35. Burton TR, Eisenstat DD, Gibson SB. BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional repressor of apoptosis-inducing factor expression preventing cell death in human malignant gliomas. J Neurosci 2009; 29: 4189-4199
36. Zhang J, Xu M. Apoptotic DNA fragmentation and tissue homeostasis. Trends cell Biol 2002; 12: 84-89
37. Kalinowska-Herok M, Widlak P. High mobility group proteins stimulate DNA cleavage by apoptotic endonuclease DFF40/CAD due to HMG-box interactions with DNA. Acta Biochim Pol 2008; 55: 21-26
38. Trisciuoglio L, Bianchi ME. Several nuclear events during apoptosis depend on caspase-3 activation but do not constitute a common pathway. PLoS One 2009; 4: E6234
39. Widlak P, Garrard WT. Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J Cell Biochem 2005; 94: 1078-1087
40. Solovyan VT, Bezvenyuk ZA, Salminen A, Austin CA, Courtney MJ. The role of topoisomerase II in the excision of DNA loop domains during apoptosis. J Biol Chem 2002; 277: 21458-21467
41. Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, Yong VW et al. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res 2001; 61: 1162-1170
42. Song JH, Song DK, Pyrzynska B, Petruk KC, Meir EG, Hao C. TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways. Brain Pathol 2003; 13: 539-553
43. Russell KJ,Wiens LW, Demers GW, Galloway DA, Plon SE, Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res 1995; 55: 1639-1642
44. Alexander BM, Pinnell N, Wen PY, DAndrea A, Targeting DNA. Repair and the cell cycle in glioblastoma. J Neurooncol 2012; 107: 463-477
45. Wakatsuki M, Ohno T, Iwakawa M, Ishikawa H, Noda S, Ohta T et al. p73 protein expression correlates with radiation-induced apoptosis in the lack of p53 response to radiation therapy for cervical cancer. Int J of Radiat Oncol Biol Phys 2008; 70: 1189-1194
46. Park MK, Kang YJ, Ha YM, Jeong JJ, Kim HJ, Seo HG et al. EP2 receptor activation by prostaglandin E2 leads to induction of HO-1 via PKA and PI3K pathways in C6 cells. Biochem Biophys Res Commun 2009; 379: 1043-1047
47. Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, Miele L et al. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 2007; 106: 417-427
48. Liu SS, Leung RCY, Chan KYK, Chiu PM, Cheung ANY, Tam KF et al. p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy. Clin Cancer Res 2004; 10: 3309-3316
49. Shinoura N, Muramatsu Y, Asai A, Han S, Horii A, Kirino T et al. Degree of apoptosis induced by adenovirus-mediated transduction of p53 or p73a depends on the p53 status of glioma cells. Cancer Lett 2000; 160: 67-73
50. Ciusani E, Croci D, Gelati M, Calatozzolo C, Sciacca F, Fumagalli L et al. In vitro effects of topotecan and ionizing radiation on TRAIL/Apo2L-mediated apoptosis in malignant glioma. J Neurooncol 2005; 71: 19-25
51. Kuijlen JMA, Van Steenbergen W, Den Dunnen WFA, Mooij JJA, Kampinga HH. Effect of g-radiation on rhTRAIL efficacy in glioblastoma multiforme cells. In: Kuijlen JMA (ed.) On TRAIL for Glioma Therapy? University Library Groningen: Groningen, The Netherlands, 2010, pp 140-153
52. Biamonti G, Caceres JF. Cellular stress and RNA splicing. Trends Biochem Sci 2009; 34: 146-153
53. Ip JY, Schmidt D, Pan Q, Ramani AK, Fraser AG, Odom DT et al. Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation. Genome Res 2011; 21: 390-401
54. Busa R, Sette C. An emerging role for nuclear RNA-mediated responses to genotoxic stress. RNA Biol 2010; 7: 390-396
55. Muñoz MJ, Santangelo M, Paronetto MP, de la Mata M, Pelisch F, Boireau S et al. DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell 2009; 137: 708-720
56. Bassi C, Mello S, Cardoso R, Godoy P, Fachin A, Junta C et al. Transcriptional changes in U343 MG-A glioblastoma cell line exposed to ionizing radiation. Hum Exp Toxicol 2008; 27: 919-929